Answers are grounded in this paper and cite their sources.
Surveillance reports high burden of Candida blankii infections in neonates, suggesting the need for better diagnostic and treatment strategies.
Invasive fungal infections (IFIs) remain underrecognized in low- and middle-income countries due to limited surveillance. This study aims to report the burden of Candida blankii infections detected through ongoing surveillance in the Neonatal Intensive Care Unit (NICU) of a tertiary hospital in Dhaka, Bangladesh. Since August 2022, IFI surveillance in a NICU in Bangladesh enrolled neonates with sepsis who met predefined clinical criteria. Blood samples were collected and processed using the BACT/ALERT 3D system, and fungal isolates were identified with automated identification system. Antifungal susceptibility testing (AFST) was performed on a subset of isolates using E-strip gradient diffusion. Whole-genome sequencing of nine representative C. blankii isolates, initially identified by VITEK MS, confirmed species identification by demonstrating 94% to 99% average nucleotide identity with reference sequences in the NCBI GenBank database. A total of 411 neonates were enrolled, with a mean age of 16 (± 7) days; 39% were male. More than half (225/411, 55%) had positive fungal blood cultures, among which C. blankii was the most common species (126/225, 31%). The isolates showed high MICs to fluconazole and voriconazole but lower MIC values against amphotericin B (AMP) and echinocandins. In-hospital mortality among C. blankii cases was significantly higher than in infections caused by other fungi. Findings indicate a substantial burden of C. blankii in the NICU and underscore the need for improved diagnostics, targeted treatment strategies, and strengthened infection control in resource-limited neonatal settings.
No takes yet. Share an insight, caveat, or question.
Shuvo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: